Light Cannabis Use and the Adolescent Brain: An 8-years Longitudinal Assessment of Mental Health, Cognition, and Reward Processing.

Adolescents Cannabis Cognition Longitudinal Psychopathology Reward Processing fMRI

Journal

Psychopharmacology
ISSN: 1432-2072
Titre abrégé: Psychopharmacology (Berl)
Pays: Germany
ID NLM: 7608025

Informations de publication

Date de publication:
26 Mar 2024
Historique:
received: 17 01 2024
accepted: 11 03 2024
medline: 27 3 2024
pubmed: 27 3 2024
entrez: 27 3 2024
Statut: aheadofprint

Résumé

For decades, cannabis has been the most widely used illicit substance in the world, particularly among youth. Research suggests that mental health problems associated with cannabis use may result from its effect on reward brain circuit, emotional processes, and cognition. However, findings are mostly derived from correlational studies and inconsistent, particularly in adolescents. Using data from the IMAGEN study, participants (non-users, persistent users, abstinent users) were classified according to their cannabis use at 19 and 22 years-old. All participants were cannabis-naïve at baseline (14 years-old). Psychopathological symptoms, cognitive performance, and brain activity while performing a Monetary Incentive Delay task were used as predictors of substance use and to analyze group differences over time. Higher scores on conduct problems and lower on peer problems at 14 years-old (n = 318) predicted a greater likelihood of transitioning to cannabis use within 5 years. At 19 years of age, individuals who consistently engaged in low-frequency (i.e., light) cannabis use (n = 57) exhibited greater conduct problems and hyperactivity/inattention symptoms compared to non-users (n = 52) but did not differ in emotional symptoms, cognitive functioning, or brain activity during the MID task. At 22 years, those who used cannabis at both 19 and 22 years-old n = 17), but not individuals that had been abstinent for ≥ 1 month (n = 19), reported higher conduct problems than non-users (n = 17). Impairments in reward-related brain activity and cognitive functioning do not appear to precede or succeed cannabis use (i.e., weekly, or monthly use). Cannabis-naïve adolescents with conduct problems and more socially engaged with their peers may be at a greater risk for lighter yet persistent cannabis use in the future.

Identifiants

pubmed: 38532040
doi: 10.1007/s00213-024-06575-z
pii: 10.1007/s00213-024-06575-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fundação para a Ciência e Tecnologia (FCT)
ID : 2021.06791.BD

Investigateurs

Gareth J Barker (GJ)
Herve Lemaitre (H)
Sabina Millenet (S)
Lauren Robinson (L)
Jeanne M Winterer (JM)

Informations de copyright

© 2024. The Author(s).

Références

Andrews JA, Tildesley E, Hops H, Li F (2002) The influence of peers on young adult substance use. Health Psychol 21(4):349–357. https://doi.org/10.1037/0278-6133.21.4.349
doi: 10.1037/0278-6133.21.4.349 pubmed: 12090677
Balodis IM, Potenza MN (2015) Anticipatory reward processing in addicted populations: A focus on the monetary incentive delay task. Biol Psychiat 77(5):434–444. https://doi.org/10.1016/j.biopsych.2014.08.020
doi: 10.1016/j.biopsych.2014.08.020 pubmed: 25481621
Benjamini Y, Krieger AM, Yekutieli D (2006) Adaptive linear step-up procedures that control the false discovery rate. Biometrika 93(3):491–507. https://doi.org/10.1093/biomet/93.3.491
doi: 10.1093/biomet/93.3.491
Blair RJ (2020) Modeling the Comorbidity of Cannabis Abuse and Conduct Disorder/Conduct Problems from a Cognitive Neuroscience Perspective. J Dual Diagn 16(1):3–21. https://doi.org/10.1080/15504263.2019.1668099
doi: 10.1080/15504263.2019.1668099 pubmed: 31608811
Broyd SJ, van Hell HH, Beale C, Yücel M, Solowij N (2016) Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review. Biol Psychiat 79(7):557–567. https://doi.org/10.1016/j.biopsych.2015.12.002
doi: 10.1016/j.biopsych.2015.12.002 pubmed: 26858214
Cavalli JM, Cservenka A (2020) Emotion Dysregulation Moderates the Association Between Stress and Problematic Cannabis Use. Front Psych 11:597789. https://doi.org/10.3389/fpsyt.2020.597789
doi: 10.3389/fpsyt.2020.597789
Cope LM, Martz ME, Hardee JE, Zucker RA, Heitzeg MM (2019) Reward activation in childhood predicts adolescent substance use initiation in a high-risk sample. Drug Alcohol Depend 194:318–325. https://doi.org/10.1016/j.drugalcdep.2018.11.003
doi: 10.1016/j.drugalcdep.2018.11.003 pubmed: 30471583
Covey DP, Wenzel JM, Cheer JF (2015) Cannabinoid modulation of drug reward and the implications of marijuana legalization. Brain Res 1628:233–243. https://doi.org/10.1016/j.brainres.2014.11.034
doi: 10.1016/j.brainres.2014.11.034 pubmed: 25463025
Degenhardt L, Coffey C, Carlin JB, Swift W, Moore E, Patton GC (2010) Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria Australia. British J Psych 196(4):290–295. https://doi.org/10.1192/bjp.bp.108.056952
doi: 10.1192/bjp.bp.108.056952
Dellazizzo L, Potvin S, Giguère S, Dumais A (2022) Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: A systematic meta-review of meta-analyses. Addiction (Abingdon, England). https://doi.org/10.1111/add.15764
Dennen CA, Blum K, Bowirrat A, Khalsa J, Thanos PK, Baron D, Badgaiyan RD, Gupta A, Braverman ER, Gold MS (2022) Neurogenetic and Epigenetic Aspects of Cannabinoids. Epigenomes 6(3):27. https://doi.org/10.3390/epigenomes6030027
doi: 10.3390/epigenomes6030027 pubmed: 36135314 pmcid: 9498086
Duperrouzel JC, Granja K, Pacheco-Colón I, Gonzalez R (2020) Adverse Effects of Cannabis Use on Neurocognitive Functioning: A Systematic Review of Meta- Analytic Studies. J Dual Diagn 16(1):43–57. https://doi.org/10.1080/15504263.2019.1626030
doi: 10.1080/15504263.2019.1626030 pubmed: 31232216
Ellingson JM, Hinckley JD, Ross JM, Schacht JP, Bidwell LC, Bryan AD, Hopfer CJ, Riggs P, Hutchison KE (2021) The Neurocognitive Effects of Cannabis Across the Lifespan. Curr Behav Neurosci Rep 8(4):124–133. https://doi.org/10.1007/s40473-021-00244-7
doi: 10.1007/s40473-021-00244-7 pubmed: 35979200 pmcid: 9377647
Enzi B, Lissek S, Edel M-A, Tegenthoff M, Nicolas V, Scherbaum N, Juckel G, Roser P (2015) Alterations of monetary reward and punishment processing in chronic cannabis users: An FMRI study. PLoS ONE 10(3):e0119150. https://doi.org/10.1371/journal.pone.0119150
doi: 10.1371/journal.pone.0119150 pubmed: 25799565 pmcid: 4370729
Farmer RF, Seeley JR, Kosty DB, Gau JM, Duncan SC, Lynskey MT, Lewinsohn PM (2015) Internalizing and externalizing psychopathology as predictors of cannabis use disorder onset during adolescence and early adulthood. Psychol Addict Behav 29(3):541–551. https://doi.org/10.1037/adb0000059
doi: 10.1037/adb0000059 pubmed: 25799438 pmcid: 4580484
Fernández-Ruiz J, Berrendero F, Hernández ML, Ramos JA (2000) The endogenous cannabinoid system and brain development. Trends Neurosci 23(1):14–20. https://doi.org/10.1016/S0166-2236(99)01491-5
doi: 10.1016/S0166-2236(99)01491-5 pubmed: 10631784
Filbey FM, Dunlop J, Myers US (2013) Neural Effects of Positive and Negative Incentives during Marijuana Withdrawal. PLoS ONE 8(5):1–12. https://doi.org/10.1371/journal.pone.0061470
doi: 10.1371/journal.pone.0061470
Filbey F, Yezhuvath U (2013) Functional connectivity in inhibitory control networks and severity of cannabis use disorder. Am J Drug Alcohol Abuse 39(6):382–391. https://doi.org/10.3109/00952990.2013.841710
doi: 10.3109/00952990.2013.841710 pubmed: 24200208 pmcid: 4318502
Francisco AP, Lethbridge G, Patterson B, Goldman Bergmann C, Van Ameringen M (2023) Cannabis use in Attention – Deficit/Hyperactivity Disorder (ADHD): A scoping review. J Psychiatr Res 157:239–256. https://doi.org/10.1016/j.jpsychires.2022.11.029
doi: 10.1016/j.jpsychires.2022.11.029 pubmed: 36508935
Gonzalez R, Pacheco-Colón I, Duperrouzel JC, Hawes SW (2017) Does Cannabis Use Cause Declines in Neuropsychological Functioning? A Review of Longitudinal Studies. J Intl Neuropsychol Soc JINS 23(9–10):893–902. https://doi.org/10.1017/S1355617717000789
doi: 10.1017/S1355617717000789
Goodman R (1997) The Strengths and Difficulties Questionnaire: A Research Note. J Child Psychol Psychiatry 38(5):581–586. https://doi.org/10.1111/j.1469-7610.1997.tb01545.x
doi: 10.1111/j.1469-7610.1997.tb01545.x pubmed: 9255702
Goodman R, Ford T, Richards H, Gatward R, Meltzer H (2000) The Development and Well-Being Assessment: Description and initial validation of an integrated assessment of child and adolescent psychopathology. J Child Psychol Psychiatry 41(5):645–655
doi: 10.1111/j.1469-7610.2000.tb02345.x pubmed: 10946756
Griffith-Lendering MFH, Huijbregts SCJ, Mooijaart A, Vollebergh WAM, Swaab H (2011) Cannabis use and development of externalizing and internalizing behaviour problems in early adolescence: A TRAILS study. Drug Alcohol Depend 116(1):11–17. https://doi.org/10.1016/j.drugalcdep.2010.11.024
doi: 10.1016/j.drugalcdep.2010.11.024 pubmed: 21208753
Grizzle R (2011) Wechsler Intelligence Scale for Children, Fourth Edition. In S. Goldstein & J. A. Naglieri (Eds.), Encyclopedia of Child Behavior and Development (pp. 1553–1555). Springer US. https://doi.org/10.1007/978-0-387-79061-9_3066
Haber SN, Knutson B (2010) The Reward Circuit: Linking Primate Anatomy and Human Imaging. Neuropsychopharmacology 35(1):4–26. https://doi.org/10.1038/npp.2009.129
doi: 10.1038/npp.2009.129 pubmed: 19812543
Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO (1991) The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict 86(9):1119–1127. https://doi.org/10.1111/j.1360-0443.1991.tb01879.x
doi: 10.1111/j.1360-0443.1991.tb01879.x pubmed: 1932883
Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87(5):1932–1936
doi: 10.1073/pnas.87.5.1932 pubmed: 2308954 pmcid: 53598
Hibell B, Guttormsson U, Ahlström S, Balakireva O, Bjarnason T, Kokkevi A, Kraus L (2012) The 2011 ESPAD report—Substance use among students in 36 European Countries. In European School Surv Proj Alcohol Drugs
Jager G, Block RI, Luijten M, Ramsey NF (2013) Tentative evidence for striatal hyperactivity in adolescent cannabis-using boys: A cross-sectional multicenter fMRI study. J Psychoactive Drugs 45(2):156–167. https://doi.org/10.1080/02791072.2013.785837
doi: 10.1080/02791072.2013.785837 pubmed: 23909003 pmcid: 3733475
Karoly HC, Bryan AD, Weiland BJ, Mayer A, Dodd A, Feldstein Ewing SW (2015) Does incentive-elicited nucleus accumbens activation differ by substance of abuse? An examination with adolescents. Dev Cogn Neurosci 16:5–15. https://doi.org/10.1016/j.dcn.2015.05.005
doi: 10.1016/j.dcn.2015.05.005 pubmed: 26070843 pmcid: 4657439
Knutson B, Greer SM (2008) Anticipatory affect: Neural correlates and consequences for choice. Philos Trans Royal Soc b: Biol Sci 363(1511):3771–3786. https://doi.org/10.1098/rstb.2008.0155
doi: 10.1098/rstb.2008.0155
Knutson B, Westdorp A, Kaiser E, Hommer D (2000) FMRI visualization of brain activity during a monetary incentive delay task. Neuroimage 12(1):20–27. https://doi.org/10.1006/nimg.2000.0593
doi: 10.1006/nimg.2000.0593 pubmed: 10875899
Lorenzetti V, Alonso-Lana S, Youssef GJ, Verdejo-Garcia A, Suo C, Cousijn J, Takagi M, Yücel M, Solowij N (2016) Adolescent Cannabis Use: What is the Evidence for Functional Brain Alteration? Curr Pharm Des 22(42):6353–6365. https://doi.org/10.2174/1381612822666160805155922
doi: 10.2174/1381612822666160805155922 pubmed: 27514709
Lorenzetti V, Hoch E, Hall W (2020) Adolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence. Eur Neuropsychopharmacol J Eur College Neuropsychopharmacol 36:169–180. https://doi.org/10.1016/j.euroneuro.2020.03.012
doi: 10.1016/j.euroneuro.2020.03.012
Lupica CR, Riegel AC, Hoffman AF (2004) Marijuana and cannabinoid regulation of brain reward circuits. Br J Pharmacol 143(2):227–234. https://doi.org/10.1038/sj.bjp.0705931
doi: 10.1038/sj.bjp.0705931 pubmed: 15313883 pmcid: 1575338
Martz ME, Cope LM, Hardee JE, Brislin SJ, Weigard A, Zucker RA, Heitzeg MM (2021) Subtypes of inhibitory and reward activation associated with substance use variation in adolescence: A latent profile analysis of brain imaging data. Cogn Affect Behav Neurosci 21(5):1101–1114. https://doi.org/10.3758/s13415-021-00907-8
doi: 10.3758/s13415-021-00907-8 pubmed: 33973159 pmcid: 9036797
Martz ME, Trucco EM, Cope LM, Hardee JE, Jester JM, Zucker RA, Heitzeg MM (2016) Association of Marijuana Use With Blunted Nucleus Accumbens Response to Reward Anticipation. JAMA Psychiat 73(8):838–844. https://doi.org/10.1001/jamapsychiatry.2016.1161
doi: 10.1001/jamapsychiatry.2016.1161
Martz ME, Zucker RA, Schulenberg JE, Heitzeg MM (2018) Psychosocial and neural indicators of resilience among youth with a family history of substance use disorder. Drug Alcohol Depend 185:198–206. https://doi.org/10.1016/j.drugalcdep.2017.12.015
doi: 10.1016/j.drugalcdep.2017.12.015 pubmed: 29462767 pmcid: 5889747
Meier MH, Caspi A, R Knodt A, Hall W, Ambler A, Harrington H, Hogan S, M Houts R, Poulton R, Ramrakha S, Hariri AR, Moffitt TE (2022) Long-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife. Am J Psych, appiajp202121060664. https://doi.org/10.1176/appi.ajp.2021.21060664
Meyer HC, Lee FS, Gee DG (2018) The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. Neuropsychopharmacology 43(1):21–33. https://doi.org/10.1038/npp.2017.143
doi: 10.1038/npp.2017.143 pubmed: 28685756
Monahan KC, Rhew IC, Hawkins JD, Brown EC (2014) Adolescent Pathways to Co-Occurring Problem Behavior: The Effects of Peer Delinquency and Peer Substance Use. J Res Adolesc 24(4):630–645. https://doi.org/10.1111/jora.12053
doi: 10.1111/jora.12053 pubmed: 25506186
Moore GF, Cox R, Evans RE, Hallingberg B, Hawkins J, Littlecott HJ, Long SJ, Murphy S (2018) School, Peer and Family Relationships and Adolescent Substance Use, Subjective Wellbeing and Mental Health Symptoms in Wales: A Cross Sectional Study. Child Indic Res 11(6):1951–1965. https://doi.org/10.1007/s12187-017-9524-1
doi: 10.1007/s12187-017-9524-1 pubmed: 30524519 pmcid: 6244918
Nestor L, Hester R, Garavan H (2010) Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users. Neuroimage 49(1):1133–1143. https://doi.org/10.1016/j.neuroimage.2009.07.022
doi: 10.1016/j.neuroimage.2009.07.022 pubmed: 19631753
Nestor LJ, Behan B, Suckling J, Garavan H (2020) Cannabis-dependent adolescents show differences in global reward-associated network topology: A functional connectomics approach. Addict Biol 25(2):e12752. https://doi.org/10.1111/adb.12752
doi: 10.1111/adb.12752 pubmed: 30957353
Oshri A, Rogosch FA, Burnette M, Cicchetti D (2011) Developmental Pathways to Adolescent Cannabis Abuse and Dependence: Child Maltreatment, Emerging Personality, and Internalizing versus Externalizing Psychopathology. Psychol Addict Behav J Soc Psychol Addict Behav 25(4):634–644. https://doi.org/10.1037/a0023151
doi: 10.1037/a0023151
Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74(2):129–180. https://doi.org/10.1016/s0163-7258(97)82001-3
doi: 10.1016/s0163-7258(97)82001-3 pubmed: 9336020
Petersen AC, Crockett L, Richards M, Boxer A (1988) A self-report measure of pubertal status: Reliability, validity, and initial norms. J Youth Adolesc 17(2):117–133. https://doi.org/10.1007/BF01537962
doi: 10.1007/BF01537962 pubmed: 24277579
Petker T, DeJesus J, Lee A, Gillard J, Owens MM, Balodis I, Amlung M, George T, Oshri A, Hall G, Schmidt L, MacKillop J (2020) Cannabis use, cognitive performance, and symptoms of attention deficit/hyperactivity disorder in community adults. Exp Clin Psychopharmacol 28(6):638–648. https://doi.org/10.1037/pha0000354
doi: 10.1037/pha0000354 pubmed: 32105137
Pike N (2011) Using false discovery rates for multiple comparisons in ecology and evolution. Methods Ecol Evol 2(3):278–282. https://doi.org/10.1111/j.2041-210X.2010.00061.x
doi: 10.1111/j.2041-210X.2010.00061.x
Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE (2012) Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage 59(3):2142–2154. https://doi.org/10.1016/j.neuroimage.2011.10.018
doi: 10.1016/j.neuroimage.2011.10.018 pubmed: 22019881
Prus AJ (2018) Drugs and the neuroscience of behavior: An introduction to psychopharmacology (Second edition). SAGE
Rubino T, Parolaro D (2016) The Impact of Exposure to Cannabinoids in Adolescence: Insights From Animal Models. Biol Psychiat 79(7):578–585. https://doi.org/10.1016/j.biopsych.2015.07.024
doi: 10.1016/j.biopsych.2015.07.024 pubmed: 26344755
Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption–II. Addiction (abingdon, England) 88(6):791–804. https://doi.org/10.1111/j.1360-0443.1993.tb02093.x
doi: 10.1111/j.1360-0443.1993.tb02093.x pubmed: 8329970
Schumann G, Loth E, Banaschewski T, Barbot A, Barker G, Büchel C, Conrod PJ, Dalley JW, Flor H, Gallinat J, Garavan H, Heinz A, Itterman B, Lathrop M, Mallik C, Mann K, Martinot J-L, Paus T, Poline J-B … Struve M (2010) The IMAGEN study: Reinforcement-related behaviour in normal brain function and psychopathology. Mol Psych, 15(12), 1128–1139. https://doi.org/10.1038/mp.2010.4
Skumlien M, Langley C, Lawn W, Voon V, Curran HV, Roiser JP, Sahakian BJ (2021) The acute and non-acute effects of cannabis on reward processing: A systematic review. Neurosci Biobehav Rev 130:512–528. https://doi.org/10.1016/j.neubiorev.2021.09.008
doi: 10.1016/j.neubiorev.2021.09.008 pubmed: 34509513
Skumlien M, Mokrysz C, Freeman TP, Wall MB, Bloomfield M, Lees R, Borissova A, Petrilli K, Carson J, Coughlan T, Ofori S, Langley C, Sahakian BJ, Curran HV, Lawn W (2022) Neural responses to reward anticipation and feedback in adult and adolescent cannabis users and controls. Neuropsychopharmacology. https://doi.org/10.1038/s41386-022-01316-2
doi: 10.1038/s41386-022-01316-2 pubmed: 35388175 pmcid: 9485226
Spechler PA, Stewart JL, Kuplicki R, Tulsa 1000 Investigators, Paulus MP (2020) Attenuated reward activations associated with cannabis use in anxious/depressed individuals. Translational Psych, 10(1), 189 https://doi.org/10.1038/s41398-020-0807-9
Squeglia LM, Jacobus J, Nguyen-Louie TT, Tapert SF (2014) Inhibition during early adolescence predicts alcohol and marijuana use by late adolescence. Neuropsychology 28(5):782–790. https://doi.org/10.1037/neu0000083
doi: 10.1037/neu0000083 pubmed: 24749728 pmcid: 4143472
Steinberg L (2008) A Social Neuroscience Perspective on Adolescent Risk-Taking. Developmental Review : DR 28(1):78–106. https://doi.org/10.1016/j.dr.2007.08.002
doi: 10.1016/j.dr.2007.08.002 pubmed: 18509515
Stringfield SJ, Torregrossa MM (2021) Disentangling the lasting effects of adolescent cannabinoid exposure. Prog Neuropsychopharmacol Biol Psychiatry 104:110067. https://doi.org/10.1016/j.pnpbp.2020.110067
doi: 10.1016/j.pnpbp.2020.110067 pubmed: 32791165
Sultan RS, Zhang AW, Olfson M, Kwizera MH, Levin FR (2023) Nondisordered Cannabis Use Among US Adolescents. JAMA Netw Open 6(5):e2311294. https://doi.org/10.1001/jamanetworkopen.2023.11294
doi: 10.1001/jamanetworkopen.2023.11294 pubmed: 37133862 pmcid: 10157425
Tong TT, Vaidya JG, Kramer JR, Kuperman S, Langbehn DR, O’Leary DS (2020) Behavioral inhibition and reward processing in college binge drinkers with and without marijuana use. Drug and Alcohol Dependence, 213. https://doi.org/10.1016/j.drugalcdep.2020.108119
van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, Ramsey NF (2010) Chronic effects of cannabis use on the human reward system: An fMRI study. Eur Neuropsychopharmacol J Eur College Neuropsychopharmacol 20(3):153–163. https://doi.org/10.1016/j.euroneuro.2009.11.010
doi: 10.1016/j.euroneuro.2009.11.010
Van Ryzin MJ, Fosco GM, Dishion TJ (2012) Family and peer predictors of substance use from early adolescence to early adulthood: An 11-year prospective analysis. Addict Behav 37(12):1314–1324. https://doi.org/10.1016/j.addbeh.2012.06.020
doi: 10.1016/j.addbeh.2012.06.020 pubmed: 22958864 pmcid: 3459354
Wechsler D (2008) Wechsler Adult Intelligence Scale: Technical and interpretive manual (Vol. 4). Psychological Corporation
Wendel LK, Daedelow L, Kaminski J, Banaschewski T, Millenet S, Bokde ALW, Quinlan EB, Desrivières S, Flor H, Grigis A, Garavan H, Gowland P, Heinz A, Brühl R, Martinot J-L, Artiges E, Nees F, Papadopoulos Orfanos D, Paus T … Walter H (2021) Residual effects of cannabis-use on neuropsychological functioning. Cognitive Dev, 59, 101072. https://doi.org/10.1016/j.cogdev.2021.101072
Yip SW, DeVito EE, Kober H, Worhunsky PD, Carroll KM, Potenza MN (2014) Pretreatment measures of brain structure and reward-processing brain function in cannabis dependence: An exploratory study of relationships with abstinence during behavioral treatment. Drug Alcohol Depend 140:33–41. https://doi.org/10.1016/j.drugalcdep.2014.03.031
doi: 10.1016/j.drugalcdep.2014.03.031 pubmed: 24793365 pmcid: 4057888

Auteurs

Inês Macedo (I)

Laboratory of Neuropsychophysiology, Faculty of Psychology and Educational Sciences (Laboratory of Neuropsychophysiology), University of Porto, Rua Alfredo Allen, 4200-135, Porto, Portugal. macedo.iines@gmail.com.
Addiction Biology Group, i3S-Instituto de Investigação E Inovação Em Saúde, Porto, Portugal. macedo.iines@gmail.com.

Tiago O Paiva (TO)

HEI-LAB, Lusófona University, Porto, Portugal.

Rita Pasion (R)

HEI-LAB, Lusófona University, Porto, Portugal.

Laura Daedelow (L)

Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin, Institute of Health, Berlin, Germany.

Andreas Heinz (A)

Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin, Institute of Health, Berlin, Germany.

Ana Magalhães (A)

Addiction Biology Group, i3S-Instituto de Investigação E Inovação Em Saúde, Porto, Portugal.
Instituto de Biologia Molecular E Celular (IBMC), University of Porto, Porto, Portugal.
Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), University of Porto, Porto, Portugal.

Tobias Banaschewski (T)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany.

Arun L W Bokde (ALW)

Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.

Sylvane Desrivières (S)

Centre for Population Neuroscience and Precision Medicine (PONS), Institute of Psychiatry, Psychology & Neuroscience, SGDP Centre, King's College London, London, UK.

Herta Flor (H)

Institute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
Department of Psychology, School of Social Sciences, University of Mannheim, 68131, Mannheim, Germany.

Antoine Grigis (A)

NeuroSpin, CEA, Université Paris-Saclay, 91191, Gif-Sur-Yvette, France.

Hugh Garavan (H)

Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, 05405, USA.

Penny Gowland (P)

Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, UK.

Rüdiger Brühl (R)

Physikalisch-Technische Bundesanstalt, Braunschweig und Berlin, Germany.

Jean-Luc Martinot (JL)

Institut National de La Santé Et de La Recherche Médicale, INSERM U 1299 Trajectoires Développementales & Psychiatrie, CNRS; EcoleNormaleSupérieure Paris-Saclay, Centre Borelli, University Paris-Saclay, Gif-Sur-Yvette, France.

Marie-Laure Paillère Martinot (MP)

Institut National de La Santé Et de La Recherche Médicale, INSERM U 1299 Trajectoires Développementales & Psychiatrie, University Paris-Saclay, CNRS; Ecole Normale Supérieure Paris-Saclay, Centre Borelli; Gif-Sur-Yvette, Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, and AP-HP. Sorbonne University, Paris, France.

Eric Artiges (E)

Institut National de La Santé Et de La Recherche Médicale, INSERM U 1299 Trajectoires Développementales & Psychiatrie, CNRS; EcoleNormaleSupérieure Paris-Saclay, Centre Borelli; Gif-Sur-Yvette; and Psychiatry Department, EPS Barthélémy Durand, University Paris-Saclay, Etampes, France.

Frauke Nees (F)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany.
Institute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
Institute of Medical Psychology and Medical Sociology, University Medical Center Schleswig Holstein, Kiel University, Kiel, Germany.

Dimitri Papadopoulos Orfanos (DP)

NeuroSpin, CEA, Université Paris-Saclay, 91191, Gif-Sur-Yvette, France.

Tomáš Paus (T)

Departments of Psychiatry and Neuroscience, Faculty of Medicine and Centre Hosptalier, Universitaire Sainte-Justine, University of Montreal, Montreal, QC, Canada.
Departments of Psychiatry and Psychology, University of Toronto, Toronto, ON, Canada.

Luise Poustka (L)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, Von-Siebold-Str. 5, 37075, Göttingen, Germany.

Sarah Hohmann (S)

Department of Child and Adolescent Psychiatry Psychotherapy and Psychosomatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Nathalie Holz (N)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany.

Juliane H Fröhner (JH)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Michael N Smolka (MN)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Nilakshi Vaidya (N)

Centre for Population Neuroscience and Stratified Medicine (PONS), Department of Psychiatry and Neuroscience, Charité Universitätsmedizin, Berlin, Germany.

Henrik Walter (H)

Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin, Institute of Health, Berlin, Germany.

Robert Whelan (R)

School of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.

Gunter Schumann (G)

Centre for Population Neuroscience and Stratified Medicine (PONS), Department of Psychiatry and Neuroscience, Charité Universitätsmedizin, Berlin, Germany.
Centre for Population Neuroscience and Precision Medicine (PONS), Institute for Science and Technology of Brain-Inspired Intelligence (ISTBI), Fudan University, Shanghai, China.

Fernando Barbosa (F)

Laboratory of Neuropsychophysiology, Faculty of Psychology and Educational Sciences (Laboratory of Neuropsychophysiology), University of Porto, Rua Alfredo Allen, 4200-135, Porto, Portugal.

Classifications MeSH